SGO Issues April 6, 2017

sgo-issues

SGO Issues April 6, 2017

Dr. Wolford elected Fellow-in-Training rep to SGO Board
SGO seeks patient anecdotes on insurance coverage gaps
Submission dates set for 2018 SGO Annual Meeting
Next SGO Connect Ed ERAS webcast April 19
2017 Annual Meeting photos on SGO Flickr account

Dr. Wolford elected Fellow-in-Training rep to SGO Board

Juliet Wolford, MD

Juliet Wolford, MD

Juliet Wolford, MD, from the University of California, Irvine, in Orange, CA, has been declared the winner of the Society’s run-off election between Fellow-in-Training Representative nominees Dr. Wolford and Sara Crafton, MD. A total of 48 percent of SGO’s fellow-in-training membership participated in this run-off election for the SGO Board of Directors.

SGO seeks patient anecdotes on insurance coverage gaps

Following Congress’ recent failure to repeal and replace the Affordable Care Act, the Society of Gynecologic Oncology is working to ensure that whatever health care reform legislation comes up in the next four years protects our patients. To that end, SGO is soliciting anecdotes of patients who have experienced financial toxicity during their cancer journey—a disruption or denial of treatment due to insurance issues. Send your anecdote to patientstories@sgo.org. Please do not include names, initials or age. Include disease type, name of drug, type of treatment or clinical trial that wasn’t covered by insurance, and type of insurance if known. Anecdotes should fall into one or more of the following categories:

  1. Patient was eligible but couldn’t participate in a clinical trial due to insurance not covering or approving
  2. Patient lost or changed insurance during treatment and suffered a delay in treatment or had to switch to a different provider/hospital system to continue their care. This includes patients who may have had “straight” Medicaid and then switched to “HMO Medicaid” and any Medicare Advantage plans, or private insurance
  3. Patient had to reduce dose, discontinue, or switch anti-cancer agents (cytotoxic or biologic) or radiation type or schedule due to increase in co-pay or deductible that made continuing treatment at recommended dose, drug type, or schedule unaffordable for them
  4. Patient was denied insurance coverage because of having a cancer diagnosis (preexisting condition)

Submission dates set for 2018 SGO Annual Meeting

The 49th SGO Annual Meeting on Women’s Cancer will be held March 24 – 27, 2018, in New Orleans, with a preconference international session on March 23. The following submission periods have been scheduled for abstracts and surgical films:

Abstracts/surgical films: Wed., July 19, 2017 – Wed., Sept. 13, 2017
Global session submissions: Wed., July 19, 2017 – Wed., Nov. 15, 2017
Late-breaking abstracts: Wed., Dec. 13, 2017 – Wed., Jan. 17, 2018

Next SGO Connect Ed ERAS webcast April 19

SGO Connect Ed will present the second half of a two-part webcast on Enhanced Recovery After Surgery (ERAS) in gynecologic oncology–“Implementing ERAS, the Nuts and Bolts”—on April 19, with moderators Jamie Bakkum-Gamez, MD, Sean Dowdy, MD, and Pedro Ramirez, MD. Topics covered will include educating staff and patients on ERAS protocol, managing expectations, data capture, tools for quality improvement, and monitoring the program.

2017 Annual Meeting photos on SGO Flickr account

Photos from the 2017 SGO Annual Meeting have now been uploaded to SGO’s Flickr account and can be downloaded directly from the page.